title: Should all screen-positive elevated blood lead (EBL) samples be retested before reporting?
authors.affiliation: Jefferson University Hospitals, Philadelphia, PA, USA.
authors.forename: Laura J
authors.initials: LJ
authors.lastname: McCloskey
authors.affiliation: University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: James D
authors.initials: JD
authors.lastname: Landmark
authors.affiliation: Jefferson University Hospitals, Philadelphia, PA, USA. Electronic address: douglas.stickle@jefferson.edu.
authors.forename: Douglas F
authors.initials: DF
authors.lastname: Stickle
mesh_terms: D001774:Blood Chemical Analysis / Q000379:methods*; D006801:Humans; D007854:Lead / Q000097:blood*; D015203:Reproducibility of Results; D012107:Research Design
chemical_list: D007854:Lead